Nucleosides and Nucleotides as Antitumor and Antiviral Agents
Elsewhere $187 $149 Save $38.00 (20%)
Free shipping Australia wide
Order Now for Christmas with e-Gift
|Format: ||Paperback, 336 pages, 1993 Edition|
|Other Information: ||18 black & white illustrations, biography|
|Published In: ||United States, 21 October 2012|
Due to the worldwide epidemic of acquired immunodeficiency syndrome (AIDS), the past ten years have witnessed a flurry of activity in the chemotherapy of viral diseases. Unprecedented scientific efforts have been made by scientists and clinicians to combat infections of human immunodeficiency virus (HIY), the causative agent. Looking back over the past ten years, we have made remarkable progress toward the treatment of the viral disease: isolation of HIV only two years after the identification of the disease, plus major strides in the areas of the molecular biology and virology of the retrovirus, etc. More remarkably, the discovery of the chemotherapeutic agent AZT (Retrovir) was made within two years after the isolation and identification of the virus, followed by unprecedented drug development efforts to culminate in the FDA approval of AZT in twenty-three months, which was a record-breaking time for approval of any drug for a major disease. The last six to seven years have particularly been an exciting and productive period for nucleoside chemists. Since the activity of AZI' was established in 1985, nucleoside chemists have had golden opportunities to discover additional anti-HIV nucleosipes, which are hoped to be less toxic and more effective than AZT, and the opportunity continues. As we all are aware, AZT possesses extremely potent anti-HIY activity, and no other nucleoside or non- nucleoside has surpassed the potency of AZT in vitro.
Table of Contents
Design of New Types of Antitumor Nucleosides (A. Matsuda et al.). Lithiation Chemistry of Uridine Derivatives (H. Tanaka et al.). A Synthesis of 2'Fluoro and 3'FluoroSubstituted Purine Nucleosides via a Direct Approach (K.W. Pankiewicz, K.A. Wantanabe). Allenols Derived from Nucleic Acid Bases-A New Class of AntiHIV Agents (J. Zemlicka). StructureActivity Relationships among HIV Inhibatory, 4'Substituted Nucleosides (E.J. Prisbe et al.). Approaches to Novel Isomeric Nucleosides as Antiviral Agents (V. Nair). Carbocyclic 7Deazaguanosine Nucleosides as Antiviral Agents (S.W. Schneller et al.). Synthesis and Anticancer and Antiviral Activity of Certain Pyramidine Nucleoside Analogues (T.S. Lin, M.C. Liu). Stereocontrolled Routes for the Synthesis of AntiHIV and AntiHBV Nucleosides (J.W. Beach et al.). 5Substituted Arabinofuranosyluracil Nucleosides as Antiherpes Agents (H. Machida, S. Sakata). 6 additional articles. Index.
Springer Book Archives
Springer-Verlag New York Inc.|
25.4 x 17.78 x 1.85 centimetres (0.66 kg)|
15+ years |